Sanofi sees faster profit growth on Dupixent, flu vaccine

French drugmaker Sanofi on forecast faster earnings growth this year on strong demand for its bestselling drug Dupixent and for its flu vaccines...

Microsoft to partner with ServBlock to develop novel business use case for NFTs in pharmaceutical compliance

ServBlock, a blockchain and pharmaceutical compliance company, is collaborating with Microsoft’s Early Access Engineering programme to produce a novel business case for the use of NFT technology in meeting compliance standards...

Virax Biolabs Group to initiate Virax Immune Covid-19 Analytical Performance Study

Virax Biolabs Group Limited (Virax), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced the initiation of its Virax Immune Covid-19 Analytical Performance Study scheduled to...

Alembic Pharma gets US FDA approval for paclitaxel injection USP

Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for paclitaxel injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL...

Novacyt's Winterplex 3G gets approval in UK under CTDA legislation

Novacyt, an international specialist in clinical diagnostics, announced that the company’s genesig Real-Time PCR SARS-CoV-2 Winterplex 3G assay panel (Winterplex 3G) has been approved in the UK under the UK Health Security Agency's Medical Devices...

Zydus Lifesciences receives USFDA approval for Micafungin injection

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Micafungin injection, 50 mg/vial and 100 mg/vial, single-dose vials (USRLD: Mycamine)...

Johnson & Johnson's blood cancer therapy gets U.S. FDA approval

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's therapy for treating a type of multiple myeloma, the company said on Tuesday, giving another treatment option to patients with the incurable blood cancer....

Indira IVF to expand its presence in eastern and southern Indian markets

Indira IVF, which has a strong presence in the western and northern regions of the country accounting for close to 70% of its total centres, is planning to aggressively expand into the eastern and southern markets in the country....

Piramal Pharma to invest in expansion and acquisitions

Piramal Pharma said it would focus on scale-up of its operations and margin growth, through a combination of organic expansion and acquisitions in the areas of contract development & manufacturing services (CDMO) and complex generics...

BioGX introduces Xfree PCR reagents for Monkeypox

To address the growing need for simplified, rapid testing for Monkeypox, BioGX, a global provider of easy molecular diagnostic solutions, announced availability of Xfree PCR reagents for Sample-to-Answer Direct Sample PCR on multiple real-time PCR...

© 2025 India Pharma Outlook. All Rights Reserved.